KIDS · NASDAQ
OrthoPediatrics Corp.
$25.50 -0.50 (-2.06%)
Company overview
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products, scoliosis procedures for the treatment of spinal deformity, and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves the pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp.
- Sector
- Healthcare
- Industry
- Medical - Devices
- Exchange
- NASDAQ
- Market cap
- $666M
- Employees
- 562
- Headquarters
- Warsaw, IN
- Website
- orthopediatrics.com
- CEO
- David R. Bailey
- Listed
- October 13, 2017
- P/E
- -15.18
- Dividend yield
- 0.00%
Company financials
- Revenue
- $243M
- Gross profit
- $178M
- Operating income
- -$29.4M
- EBITDA
- -$11.9M
- Net income
- -$39.7M
- EPS
- -$1.68
- Total assets
- $502M
- Total debt
- $106M
- Gross margin
- 73.07%
- Net margin
- -16.31%
- Earnings yield
- -6.59%
Showing FY 2025
KIDS
1D
NASDAQ
O24.09H24.38L23.78C23.80-0.22 (-0.92%)Vol78.47K